Page 99 - Sohini Das

Hindustan Antibiotics seeks redemption amid rising anti-China sentiments

The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme

Dexamethasone and remdesivir included in Covid-19 treatment protocol

The Ministry of Health and Family Welfare (MoHFW) on Saturday released the updated clinical management protocol for managing Covid-19 cases

Piramal sells 20% in pharmaceutical business to Carlyle for $490 mn

Carlyle will pick up a 20 per cent stake for $490 million or around Rs 3,700 crore in the pharma subsidiary called Piramal Pharma Ltd

India's coronavirus drug market set for price war as firms ready launches

Sources say Cipla-BDR's favipiravir will be at least 30 per cent cheaper than Glenmark's price of Rs 103 per tablet. Cipla did not confirm.

Marico Foundation rewards innovators making a difference in Covid fight

Three products that offer innovative and affordable protective solutions have been selected

Govt mulls faster drug approval process, regulatory system overhaul

The industry, which has been lobbying for faster approvals for quite some time now, says the current pandemic should help expedite the reforms process

Mumbai docs want key drugs made available fast as hospital wards swell up

If patients recover faster, they needn't stay in hospital for 14 days and this could free up beds; Remdesivir and Favipiravir are in the process of being made available in India

Trump's focus on local drugs not immediate concern: Indian pharma industry

US is one of the major export destinations for drugmakers in India, accounting for roughly 33 per cent of the country's drug exports

Covid-19 lockdown: After April shock, drug sales improve in May

Till May 15, the overall inventory was 39 days, compared to 43 days in first half of the previous month

Covid-19: Pune-based drug firm to export favipiravir to 18 countries

Favipiravir is under trial in many countries as a potential treatment for Covid-19

Govt may consider expanding Jan Aushadhi pathology centres to block level

Private diagnostic players' business has been hit due to lockdown; open to PPP

Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US

Injectibles account for 60% of crunch; most plants under American regulator's lens the past two months have now received positive outcomes

How Covid-19 gave a push to domestic med tech manufacturing industry

From PPEs to ventilators to face shields, manufacturers have invested money to ramp up production and deliver during this crisis

Centre keen on testing Gilead's remdesivir to combat coronavirus

The USFDA has recently given an emergency approval to the drug for use on coronavirus patients

Mumbai scrambles to add critical care infrastructure amid Covid-19 spread

Projection says city may have 75,000 cases by May-end

PPEs, work-life balance the new normal as pharma salesforce hits the field

GSK leads the charge with staggered return-to-work, others plans yoga sessions and health care webinars for salesperson's family

Covid-19 impact: Indian firms look to fill in for US' Famotidine crunch

Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation

Lockdown 3.0: Pharma hubs take extra precaution to tame Covid-19 outbreak

Recently, while 26 workers at Cadila Pharmaceuticals facility in Ahmedabad tested positive for Covid-19, one person at Sun Pharma's Halol plant tested positive.

Govt in talks with industry on production of Gilead's remdesivir for trials

Checks with industry on when can production begin here for trials

Govt allows import of superior testing technologies in Covid-19 battle

Players like Abbott, Roche, Trivitron, Eris get approvals to import chemiluminescent kits, ELISA kits too get nod